Sen. Chuck Grassley (R-IA) chided HHS appropriations conferees for axing his bipartisan amendment giving FDA money to require drug prices be disclosed on direct-to-consumer ads, but he added HHS still has the authority to mandate the disclosure. “The good news is that the Department of Health and Human Services has the authority to make this happen. Secretary Azar has spoken clearly about his support for this policy and transparency on behalf of consumers concerning prescription drugs. The Administration has also...